These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 8818779)
1. Choice of metal ion and formulation concentration for first-pass brain perfusion studies with magnetic resonance imaging at 1.5 tesla. Runge VM; Wells JW Invest Radiol; 1996 Jul; 31(7):395-400. PubMed ID: 8818779 [TBL] [Abstract][Full Text] [Related]
2. Detectability of small liver metastases with gadolinium BOPTA. Runge VM; Lee C; Williams NM Invest Radiol; 1997 Sep; 32(9):557-65. PubMed ID: 9291044 [TBL] [Abstract][Full Text] [Related]
3. Hepatic abscesses. Magnetic resonance imaging findings using gadolinium-BOPTA. Runge VM; Wells JW; Williams NM Invest Radiol; 1996 Dec; 31(12):781-8. PubMed ID: 8970881 [TBL] [Abstract][Full Text] [Related]
4. Comparison of gadolinium Cy2DOTA, a new hepatobiliary agent, and gadolinium HP-DO3A, an extracellular agent, in healthy liver and metastatic disease. Runge VM; Wells JW; Williams NM Invest Radiol; 1995 Feb; 30(2):123-30. PubMed ID: 7782188 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of gadolinium 2,5-BPA-DO3A, a new macrocyclic hepatobiliary chelate, in normal liver and metastatic disease on high field magnetic resonance imaging. Runge VM; Wells JW; Williams NM Invest Radiol; 1996 Jan; 31(1):11-6. PubMed ID: 8850360 [TBL] [Abstract][Full Text] [Related]
6. Assessment of cerebral perfusion by first-pass, dynamic, contrast-enhanced, steady-state free-precession MR imaging: an animal study. Runge VM; Kirsch JE; Wells JW; Woolfolk CE AJR Am J Roentgenol; 1993 Mar; 160(3):593-600. PubMed ID: 8430562 [TBL] [Abstract][Full Text] [Related]
7. Does a higher concentration of gadolinium chelates improve first-pass cardiac signal changes? Tombach B; Reimer P; Prümer B; Allkemper T; Bremer C; Mühler A; Heindel W J Magn Reson Imaging; 1999 Nov; 10(5):806-12. PubMed ID: 10548792 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of standard and high-dose contrast-enhanced breath-hold liver magnetic resonance for visualization of metastatic disease in an animal model. Runge VM Invest Radiol; 1998 May; 33(5):263-7. PubMed ID: 9609484 [TBL] [Abstract][Full Text] [Related]
9. Contrast-enhanced magnetic resonance imaging in a spinal epidural tumor model. Runge VM; Lee C; Iten AL; Williams NM Invest Radiol; 1997 Oct; 32(10):589-95. PubMed ID: 9342117 [TBL] [Abstract][Full Text] [Related]
10. Early dynamic magnetic resonance imaging of liver metastases with 0.3 and 0.6 mmol/kg gadoteridol injection. Runge VM; Wells JW; Williams NM Invest Radiol; 1996 Aug; 31(8):472-8. PubMed ID: 8854193 [TBL] [Abstract][Full Text] [Related]
11. Acute hemodynamic effects of recently developed monomer and dimer magnetic resonance imaging contrast media: a comparative study. Geschwind JF; Saeed M; Wendland MF; Szolar D; Derugin N; Higgins CB Acad Radiol; 1996 Aug; 3(8):667-77. PubMed ID: 8796731 [TBL] [Abstract][Full Text] [Related]
12. Formulation and characterisation of magnetic resonance imageable thermally sensitive liposomes for use with magnetic resonance-guided high intensity focused ultrasound. Negussie AH; Yarmolenko PS; Partanen A; Ranjan A; Jacobs G; Woods D; Bryant H; Thomasson D; Dewhirst MW; Wood BJ; Dreher MR Int J Hyperthermia; 2011; 27(2):140-55. PubMed ID: 21314334 [TBL] [Abstract][Full Text] [Related]
13. Comparison of iron oxide particles (AMI 227) with a gadolinium complex (Gd-DOTA) in dynamic susceptibility contrast MR imagings (FLASH and EPI) for both phantom and rat brain at 1.5 Tesla. Loubeyre P; De Jaegere T; Bosmans H; Miao Y; Ni Y; Landuyt W; Marchal G J Magn Reson Imaging; 1999 Mar; 9(3):447-53. PubMed ID: 10194716 [TBL] [Abstract][Full Text] [Related]
15. Haemodynamic effects of macrocyclic and linear gadolinium chelates in rats: role of calcium and transmetallation. Idée JM; Berthommier C; Goulas V; Corot C; Santus R; Hermine C; Schaefer M; Bonnemain B Biometals; 1998 Apr; 11(2):113-23. PubMed ID: 9542065 [TBL] [Abstract][Full Text] [Related]
16. Combination of gadolinium and dysprosium chelates as a cellular integrity marker in MR imaging. Ericsson A; Bach-Gansmo T; Niklasson F; Hemmingsson A Acta Radiol; 1995 Jan; 36(1):41-6. PubMed ID: 7833167 [TBL] [Abstract][Full Text] [Related]
17. Gd-HP-DO3A in clinical MR imaging of the brain. Runge VM; Gelblum DY; Pacetti ML; Carolan F; Heard G Radiology; 1990 Nov; 177(2):393-400. PubMed ID: 2217775 [TBL] [Abstract][Full Text] [Related]
18. [Gd(HB-DO3A)]: Equilibrium, Dissociation Kinetic and Structural Differences in a Simple Homolog of [Gd(HP-DO3A)] (Prohance Versolatto S; Boccalon M; Guidolin N; Travagin F; Alessio E; Aime S; Balducci G; Giovenzana GB; Baranyai Z Chemistry; 2024 May; 30(28):e202400344. PubMed ID: 38469901 [TBL] [Abstract][Full Text] [Related]
19. A comparison of two MR hepatobiliary gadolinium chelates: Gd-BOPTA and Gd-EOB-DTPA. Runge VM J Comput Assist Tomogr; 1998; 22(4):643-50. PubMed ID: 9676461 [TBL] [Abstract][Full Text] [Related]